Active Surveillance-Is It Feasible for Intermediate-risk Localised Prostate Cancer?

Eur Urol Open Sci · 2021 · PMC8317861 · PMID 34337491

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Interestingly, the indication of AS has gradually expanded from the LRPC to the intermediate-risk prostate cancer (IRPC) group, and there is an increasing trend to manage IRPC patients expectantly.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.